Montero A - Search Results

1

EST79232 and EST79376, Two Novel Sigma-1 Receptor Ligands, Exert Neuroprotection on Models of Motoneuron Degeneration.

Gaja-Capdevila N, Hernández N, Yeste S, Reinoso RF, Burgueño J, Montero A, Merlos M, Vela JM, Herrando-Grabulosa M, Navarro X. Gaja-Capdevila N, et al. Among authors: montero a. Int J Mol Sci. 2022 Jun 16;23(12):6737. doi: 10.3390/ijms23126737. Int J Mol Sci. 2022. PMID: 35743175 Free PMC article.

2

Tricyclic Triazoles as σ₁ Receptor Antagonists for Treating Pain.

Díaz JL, Cuevas F, Oliva AI, Font D, Sarmentero MÁ, Álvarez-Bercedo P, López-Valbuena JM, Pericàs MA, Enrech R, Montero A, Yeste S, Vidal-Torres A, Álvarez I, Pérez P, Cendán CM, Cobos EJ, Vela JM, Almansa C. Díaz JL, et al. Among authors: montero a. J Med Chem. 2021 Apr 22;64(8):5157-5170. doi: 10.1021/acs.jmedchem.1c00244. Epub 2021 Apr 7. J Med Chem. 2021. PMID: 33826322

3

Pharmacological properties of S1RA, a new sigma-1 receptor antagonist that inhibits neuropathic pain and activity-induced spinal sensitization.

Romero L, Zamanillo D, Nadal X, Sánchez-Arroyos R, Rivera-Arconada I, Dordal A, Montero A, Muro A, Bura A, Segalés C, Laloya M, Hernández E, Portillo-Salido E, Escriche M, Codony X, Encina G, Burgueño J, Merlos M, Baeyens JM, Giraldo J, López-García JA, Maldonado R, Plata-Salamán CR, Vela JM. Romero L, et al. Among authors: montero a. Br J Pharmacol. 2012 Aug;166(8):2289-306. doi: 10.1111/j.1476-5381.2012.01942.x. Br J Pharmacol. 2012. PMID: 22404321 Free PMC article.

4

Synthesis and structure-activity relationship study of a new series of selective σ(1) receptor ligands for the treatment of pain: 4-aminotriazoles.

Díaz JL, Christmann U, Fernández A, Torrens A, Port A, Pascual R, Álvarez I, Burgueño J, Monroy X, Montero A, Balada A, Vela JM, Almansa C. Díaz JL, et al. Among authors: montero a. J Med Chem. 2015 Mar 12;58(5):2441-51. doi: 10.1021/jm501920g. Epub 2015 Feb 19. J Med Chem. 2015. PMID: 25658964

5

Pyrazolo[3,4-d]pyrimidines as sigma-1 receptor ligands for the treatment of pain. Part 1: 4-acylamino derivatives.

Díaz JL, Corbera J, Cuberes R, Contijoch M, Enrech R, Yeste S, Montero A, Dordal A, Monroy X, Almansa C. Díaz JL, et al. Among authors: montero a. Medchemcomm. 2017 Apr 20;8(6):1235-1245. doi: 10.1039/c7md00077d. eCollection 2017 Jun 1. Medchemcomm. 2017. PMID: 30108834 Free PMC article.

6

EST64454: a Highly Soluble σ₁ Receptor Antagonist Clinical Candidate for Pain Management.

Díaz JL, García M, Torrens A, Caamaño AM, Enjo J, Sicre C, Lorente A, Port A, Montero A, Yeste S, Álvarez I, Martín M, Maldonado R, de la Puente B, Vidal-Torres A, Cendán CM, Vela JM, Almansa C. Díaz JL, et al. Among authors: montero a. J Med Chem. 2020 Dec 10;63(23):14979-14988. doi: 10.1021/acs.jmedchem.0c01575. Epub 2020 Nov 25. J Med Chem. 2020. PMID: 33237785

7

Pharmacological activation of 5-HT7 receptors reduces nerve injury-induced mechanical and thermal hypersensitivity.

Brenchat A, Nadal X, Romero L, Ovalle S, Muro A, Sánchez-Arroyos R, Portillo-Salido E, Pujol M, Montero A, Codony X, Burgueño J, Zamanillo D, Hamon M, Maldonado R, Vela JM. Brenchat A, et al. Among authors: montero a. Pain. 2010 Jun;149(3):483-494. doi: 10.1016/j.pain.2010.03.007. Pain. 2010. PMID: 20399562

8

Pyrazolo[3,4-d]pyrimidines as sigma-1 receptor ligands for the treatment of pain. Part 2: Introduction of cyclic substituents in position 4.

Díaz JL, Corbera J, Martínez D, Bordas M, Sicre C, Pascual R, Pretel MJ, Marín AP, Montero A, Dordal A, Alvarez I, Almansa C. Díaz JL, et al. Among authors: montero a. Medchemcomm. 2017 Apr 20;8(6):1246-1254. doi: 10.1039/c7md00078b. eCollection 2017 Jun 1. Medchemcomm. 2017. PMID: 30108835 Free PMC article.

9

Guanidinium and aminoimidazolinium derivatives of N-(4-piperidyl)propanamides as potential ligands for mu opioid and I2-imidazoline receptors: synthesis and pharmacological screening.

Montero A, Goya P, Jagerovic N, Callado LF, Meana JJ, Girón R, Goicoechea C, Martín MI. Montero A, et al. Bioorg Med Chem. 2002 Apr;10(4):1009-18. doi: 10.1016/s0968-0896(01)00356-x. Bioorg Med Chem. 2002. PMID: 11836109

10

Studies on aromatic compounds: inhibition of calpain I by biphenyl derivatives and peptide-biphenyl hybrids.

Montero A, Alonso M, Benito E, Chana A, Mann E, Navas JM, Herradón B. Montero A, et al. Bioorg Med Chem Lett. 2004 Jun 7;14(11):2753-7. doi: 10.1016/j.bmcl.2004.03.071. Bioorg Med Chem Lett. 2004. PMID: 15125927

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

710 results

Search Page